Interestingly, breast cancer progression was associated with elevated expression of β3 integrin and its effector, FAK, which correlated with the conversion of TGF-β from a suppressor to a promoter of breast cancer progression (Figure 9a). The gene discussed is TGFB1; the disease is breast carcinoma.